Drawing for PROBONO PHARMA

USPTO serial 78447453

PROBONO PHARMA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
ERVIN, INGA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PROBONO PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lawrence E. Abelman

LAWRENCE E ABELMAN ABELMAN FRAYNE & SCHWAB666 3RD AVE 10TH FLNEW YORK, NY 10017UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Acne medications, acne treatment preparations, adjuvants for use with vaccines, adjuvants for use with vaccines, allergy capsules, allergy medications, allergy relief medication, allergy tablets, dental amalgams, analgesics, oral analgesics, topical analgesics, antacids, anthelmintics, anti-infectives, anti-inflammatories, antiarrhythmics, antibacterial pharmaceuticals, antibiotic creams, antibiotic ointments, antibiotic tablets, antibiotics, anticoagulants, anticoagulants used as pharmaceutical preparations, anticonvulsants, anticonvulsants, antidepressants, antidepressants used as pharmaceutical preparations, antidotes to counteract poisons, antiemetics, antiflatulants, antihistamines, antihypertensives, antiparasitics, antiseptics, antivirals, appetite suppressants, appetite suppressants used as pharmaceutical preparations, astringents for medicinal purposes, baby food, bronchial dilators, bronchodialators, burn relief medication, calcium channel blockers, calcium supplements, medicated candy, cardiovascular pharmaceuticals, cardiovascular treatment preparations, central nervous system stimulants, pharmaceutical preparations for use in chemotherapy, medicated chewing gum, cholesterol reducers, preparations for treating colds, medicated compresses, oral contraceptives, cough drops, cough expectorants, cough lozenges, cough syrups, cough treatment preparations, antibiotic cream, hydrocortisone cream, decongestant capsules, decongestant nasal sprays, decongestants, dermatologicals, diarrhea medication, dietary drink mix for use as a meal replacement, dietary food supplements, dietary supplements, diuretic preparations, douches, dietary drink mix for use as a meal replacement, nutritional drink mix for use as a meal replacement, ear drops, eye drops, nose drops, ear drops, emetic preparations, enema preparations, epsom salts, expectorants, cough expectorants, eye drops, eye washes, food for infants, food for medically restricted diets, food supplements, dietary food supplements, fungal medications, gastro-intestinal treatment preparations, topical gel for medical and therapeutic use, glaucoma agents, pharmaceutical preparation for the treatment of gout, medicated gum, pharmaceutical preparations for the treatment of heart rhythm disorders, hemorrhoid treatment preparations, hemorrhoidal ointments, herb teas for medicinal purposes, herbal supplements, hormones, preparations for the suppression of hormones, hydrocortisone cream, hydrogen peroxide for medical use, hypnotics, ibuprofen for use as an oral analgesic, food for infants, laxatives, medicated skin care preparations, menstrual symptom treatment preparations, merthiolate, migraine treatment preparations, mineral and vitamin supplements, motion sickness treatment preparations, anticavity mouth rinses, medicated mouthwash, muscle relaxants, muscle soaks, nail fungus treatment preparations, nasal spray preparations, nausea treatment preparations, nose drops, nutritional drink mix for use as a meal replacement, nutritional supplements, oral analgesics, pain relief medication, hydrogen peroxide for medical use, psychotropics, sedatives, medicated skin care preparations, steroids, dietary supplements, food supplements, herbal supplements, mineral supplements, nutritional supplements, suppositories, throat lozenges, topical analgesics, topical anesthetics, topical gel for medical and therapeutic use, tranquilizers, transdermal patches, vaccine adjuvants, vaccines, vaginal preparations, namely, antifungals, vitamins, wart removing preparationsACTIVE—
010Medical diagnostic apparatusACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 2, 2010MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 2, 2010ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 29, 2009NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 6, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 16, 2009NPUBNOTICE OF PUBLICATION—
Aug 31, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 27, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 19, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 18, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 18, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 18, 2009CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 18, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 9, 2009ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jan 16, 2009PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jan 5, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 5, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 12, 2008CNEAEXAMINERS AMENDMENT MAILED—
Dec 12, 2008XAECEXAMINER'S AMENDMENT ENTERED—
Dec 12, 2008CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 4, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 4, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 4, 2008ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Sep 8, 2008RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jun 17, 2008RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Dec 17, 2007RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Oct 18, 2007RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Mar 22, 2007RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jan 12, 2007RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 12, 2007ALIEASSIGNED TO LIE—
Jun 23, 2006CNSLLETTER OF SUSPENSION MAILED—
Jun 23, 2006CNSLSUSPENSION LETTER WRITTEN—
Jun 2, 2006ACECAMENDMENT FROM APPLICANT ENTERED—
May 8, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 8, 2006MAILPAPER RECEIVED—
Mar 28, 2006CNSIINQUIRY AS TO SUSPENSION MAILED—
Mar 28, 2006CNSISUSPENSION INQUIRY WRITTEN—
Mar 8, 2006ACECAMENDMENT FROM APPLICANT ENTERED—
Feb 7, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 7, 2006MAILPAPER RECEIVED—
Sep 6, 2005CNSLLETTER OF SUSPENSION MAILED—
Sep 6, 2005CNSLSUSPENSION LETTER WRITTEN—
Aug 15, 2005TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 10, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 10, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 14, 2005CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 11, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 11, 2005DOCKASSIGNED TO EXAMINER—
Jul 14, 2004NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance